Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.7 |
mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | GW 441756 | GDSC1000 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.7 |
mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.034 | 0.7 |
mRNA | Vinorelbine | GDSC1000 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |